Selectis Health (GBCS) director reports initial share holdings on Form 3

Rhea-AI Filing Summary

Selectis Health, Inc. director Kent J. Lund filed an initial ownership report listing his beneficial holdings of the company’s voting common shares. He reports direct ownership of 15,992 voting common shares and indirect beneficial ownership of 3,261 voting common shares held through his spouse’s IRA. This filing establishes his starting ownership position as of January 1, 2026.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Lund Kent Jeffrey

Role Director

Type	Security	Shares	Price	Value
holding	Voting Common Shares	--	--	--
holding	Voting Common Shares	--	--	--

Holdings After Transaction: Voting Common Shares — 15,992 shares (Direct); Voting Common Shares — 3,261 shares (Indirect, Spouse Ownership in IRA)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 01/15/2026 - 06:13 AM Learn about SEC filing dates

FAQ

Who is the reporting insider in the Selectis Health (GBCS) Form 3 filing?

The reporting insider is Kent Jeffrey Lund, who is identified as a director of Selectis Health, Inc.

What type of security does Kent Lund report owning in Selectis Health (GBCS)?

Kent Lund reports beneficial ownership of Voting Common Shares of Selectis Health, Inc.

How many Selectis Health (GBCS) shares does Kent Lund own directly and indirectly?

He reports 15,992 voting common shares held directly and 3,261 voting common shares held indirectly through his spouse’s IRA.

What is the nature of Kent Lund’s indirect ownership of Selectis Health (GBCS) shares?

The indirect ownership relates to Spouse Ownership in IRA, meaning 3,261 voting common shares are held in his spouse’s IRA account.

Does the Selectis Health (GBCS) Form 3 show any derivative securities held by Kent Lund?

The Form 3 includes a table for derivative securities, but no derivative positions are reported for Kent Lund in the provided content.

What is the event date for Kent Lund’s initial ownership report for Selectis Health (GBCS)?

The date of the event requiring the statement is listed as January 1, 2026.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lund Kent Jeffrey

(Last) (First) (Middle)

203 SOUTH PONTIAC STREET

(Street)

DENVER CO 80230

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2026

3. Issuer Name and Ticker or Trading Symbol
SELECTIS HEALTH, INC. [ GBCS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Voting Common Shares	15,992	D
Voting Common Shares	3,261	I	Spouse Ownership in IRA

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Kent J. Lund	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.